Estimation of Outcome and Quality of Life in ECMO Patients
ConditionExtracorporeal Membrane Oxygenation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHeinrich-Heine University, Duesseldorf
About this trial
The availability as well as the use of extracorporeal membrane oxygenation (ECMO) systems for severe acute respiratory or cardiocirculatory failure is steadily increasing. The decision to initiate ECMO therapy is predominantly made in emergency situations, for which the focus is on acute survival. The decisions if a patient will profit from ECMO therapy are mainly made from clinical experience and educated guess by the attending team. However, it is unknown how useful these clinical predictions are. Therefore, this observational study will compare estimated and real outcome of ECMO patients.
Eligibility criteria
Qualifiers
age ≥ 18 years
start of ECMO therapy ≤24h
written informed consent from patient or health-care proxy
Disqualifiers
age < 18 years
Language barrier (communication in German/local language or English not possible).
no ECMO therapy or ECMO therapy longer than 24h
no written consent
Trial design
Treatments tested in this trial
- estimation of patient outcome by health care providers
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov